Invectys publishes positive clinical results for its INVAC-1 Phase I Study in Clinical Cancer Research With an extended Phase I and a new delivery method…
Invectys : lutter contre toutes les formes de cancers Avec 382 000 nouveaux cas et 157 400 décès par an, le cancer demeure une priorité absolue en matière de…
8th International Conference on HLA-G July 8th – 9th 2019 Ministère de la Santé et des Solidarités, Paris, France Invectys will be attending the 8th International…
Invectys élu « meilleur projet – jeune entreprise » 2019 par le Board international de MATWIN Invectys, société biopharmaceutique développant des thérapies…
Healthtech Investor Day June 24th – 25th, 2019 The Peninsula Paris, Paris, France Pierre Langlade-Demoyen, our CEO, will be representing Invectys…
Bio International Convention 2019 June 3 – 6th 2019 Pennsylvania Convention Center, Philadelphia, Pennsylvania, USA Invectys will be attending the BIO International…
ASCO Annual meeting 2019 May 31st – June 4th 2019 McCormick Place, Chicago, Illinois, USA Invectys will be attending the 2019 ASCO Annual Meeting,…
ICVI International Symposium on Immunotherapy May 24th – 25th, 2019 The Royal Society, London, UK Invectys will be attending the Institute for…
